1. Home
  2. MBX vs TECX Comparison

MBX vs TECX Comparison

Compare MBX & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBX
  • TECX
  • Stock Information
  • Founded
  • MBX 36
  • TECX 2019
  • Country
  • MBX United States
  • TECX United States
  • Employees
  • MBX N/A
  • TECX N/A
  • Industry
  • MBX
  • TECX
  • Sector
  • MBX
  • TECX
  • Exchange
  • MBX NYSE
  • TECX Nasdaq
  • Market Cap
  • MBX 644.6M
  • TECX 746.6M
  • IPO Year
  • MBX 2024
  • TECX 2018
  • Fundamental
  • Price
  • MBX $10.93
  • TECX $48.01
  • Analyst Decision
  • MBX Strong Buy
  • TECX Strong Buy
  • Analyst Count
  • MBX 4
  • TECX 5
  • Target Price
  • MBX $37.25
  • TECX $80.50
  • AVG Volume (30 Days)
  • MBX 292.8K
  • TECX 523.4K
  • Earning Date
  • MBX 02-16-2025
  • TECX 02-24-2025
  • Dividend Yield
  • MBX N/A
  • TECX N/A
  • EPS Growth
  • MBX N/A
  • TECX N/A
  • EPS
  • MBX N/A
  • TECX N/A
  • Revenue
  • MBX N/A
  • TECX N/A
  • Revenue This Year
  • MBX N/A
  • TECX N/A
  • Revenue Next Year
  • MBX N/A
  • TECX N/A
  • P/E Ratio
  • MBX N/A
  • TECX N/A
  • Revenue Growth
  • MBX N/A
  • TECX N/A
  • 52 Week Low
  • MBX $9.42
  • TECX $1.40
  • 52 Week High
  • MBX $27.50
  • TECX $61.07
  • Technical
  • Relative Strength Index (RSI)
  • MBX N/A
  • TECX 53.70
  • Support Level
  • MBX N/A
  • TECX $15.30
  • Resistance Level
  • MBX N/A
  • TECX $61.07
  • Average True Range (ATR)
  • MBX 0.00
  • TECX 6.30
  • MACD
  • MBX 0.00
  • TECX 1.33
  • Stochastic Oscillator
  • MBX 0.00
  • TECX 71.47

About MBX MBX BIOSCIENCES INC

MBX Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.

Share on Social Networks: